102331
For the active immunisation of cattle against Infectious Bovine Rhinotracheitis (IBR), to reduce virus shedding and clinical signs including, in female cattle, abortions associated with BHV-1 infection. A reduction in abortions associated with BHV-1 infection has been demonstrated during the second trimester of gestation following challenge 28 days after vaccination.
Onset of immunity: 4 weeks (at the latest) after completion of the primary course of vaccination, as demonstrated by challenge.
Duration of immunity: 6 months.
NOTE: This is the Live vaccine.
Dosage & Administration
2 ml reconstituted vaccine.
Route:
Intranasal and/or intramuscular inoculation. The vaccine must be administered aseptically via the intramuscular route (2 ml) or sprayed into the nostrils (1 ml per nostril during aspiration) with the intranasal applicator.